Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, Hidetoshi Itani, et al. Phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non-small-cell lung cancer: TORG1937 (DATE study). Clinical cancer research : an official journal of the American Association for Cancer Research. 2024
Sumiko Abe, Mina Yasuda, Kazunori Tobino, Sonoko Harada, Hitoshi Sasano, Yuki Tanabe, Yuuki Sandhu, Tomohito Takeshige, Kei Matsuno, Tetsuhiko Asao, et al. Usefulness of Computed Tomography for Evaluating the Effects of Bronchial Thermoplasty in Japanese Patients with Severe Asthma. Journal of asthma and allergy. 2024. 17. 325-337
Masahiro Torasawa, Hidehito Horinouchi, Shogo Nomura, Satoshi Igawa, Maiko Asai, Hidenobu Ishii, Hiroshi Wakui, Ryota Ushio, Tetsuhiko Asao, Yukiko Namba, et al. Reconsidering the cutoff value for sensitive and refractory relapses in extensive-stage small cell lung cancer in the era of immunotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2023
Tetsuhiko Asao, Takehito Shukuya, Tomoyasu Mimori, Yasushi Goto, Hiroshi Tanaka, Koichi Takayama, Yukari Tsubata, Motoko Tachihara, Takuji Suzuki, Kyoichi Kaira, et al. Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101). Clinical lung cancer. 2023
Koichiro Kanamori, Kentaro Suina, Takehito Shukuya, Fumiyuki Takahashi, Takuo Hayashi, Kieko Hara, Tsuyoshi Saito, Yoichiro Mitsuishi, Shoko Sonobe Shimamura, Wira Winardi, et al. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma. Thoracic cancer. 2023. 14. 12. 1089-1097